Dearborn Partners LLC Invests $294,000 in UnitedHealth Group Incorporated (NYSE:UNH)

Dearborn Partners LLC purchased a new position in UnitedHealth Group Incorporated (NYSE:UNH) in the 3rd quarter, Holdings Channel.com reports. The fund purchased 503 shares of the healthcare conglomerate’s stock, valued at approximately $294,000.

Other institutional investors and hedge funds have also recently modified their holdings of the company. CIBC Asset Management Inc increased its stake in UnitedHealth Group by 6.1% in the 3rd quarter. CIBC Asset Management Inc now owns 379,492 shares of the healthcare conglomerate’s stock worth $221,779,000 after purchasing an additional 21,669 shares during the period. FUKOKU MUTUAL LIFE INSURANCE Co raised its holdings in UnitedHealth Group by 15.2% during the 3rd quarter. FUKOKU MUTUAL LIFE INSURANCE Co now owns 4,932 shares of the healthcare conglomerate’s stock valued at $2,884,000 after buying an additional 650 shares during the last quarter. Broderick Brian C grew its holdings in UnitedHealth Group by 0.5% in the 3rd quarter. Broderick Brian C now owns 21,497 shares of the healthcare conglomerate’s stock worth $12,569,000 after acquiring an additional 100 shares during the last quarter. Oak Harbor Wealth Partners LLC raised its stake in shares of UnitedHealth Group by 7.4% during the third quarter. Oak Harbor Wealth Partners LLC now owns 1,869 shares of the healthcare conglomerate’s stock valued at $1,093,000 after acquiring an additional 128 shares during the last quarter. Finally, Sargent Investment Group LLC increased its holdings in UnitedHealth Group by 22.4% during the 3rd quarter. Sargent Investment Group LLC now owns 4,735 shares of the healthcare conglomerate’s stock valued at $2,768,000 after purchasing an additional 867 shares during the period. 87.86% of the stock is owned by institutional investors.

UnitedHealth Group Stock Down 0.2 %

UNH stock opened at $592.18 on Friday. The company has a debt-to-equity ratio of 0.74, a current ratio of 0.91 and a quick ratio of 0.91. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The stock has a market capitalization of $544.97 billion, a P/E ratio of 38.58, a P/E/G ratio of 1.78 and a beta of 0.58. The business has a fifty day moving average price of $582.95 and a 200-day moving average price of $548.34.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, October 15th. The healthcare conglomerate reported $7.15 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $7.00 by $0.15. UnitedHealth Group had a net margin of 3.63% and a return on equity of 26.37%. The firm had revenue of $100.82 billion for the quarter, compared to the consensus estimate of $99.14 billion. During the same quarter last year, the firm posted $6.56 EPS. The business’s quarterly revenue was up 9.2% compared to the same quarter last year. Equities analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 17th. Shareholders of record on Monday, December 9th will be given a $2.10 dividend. The ex-dividend date is Monday, December 9th. This represents a $8.40 annualized dividend and a yield of 1.42%. UnitedHealth Group’s payout ratio is 54.72%.

Analysts Set New Price Targets

Several equities analysts have recently issued reports on the company. Truist Financial reissued a “buy” rating and set a $625.00 target price (down from $640.00) on shares of UnitedHealth Group in a research note on Wednesday, October 16th. Stephens cut their target price on shares of UnitedHealth Group from $632.00 to $605.00 and set an “overweight” rating on the stock in a research note on Wednesday, October 16th. Bank of America lowered their price objective on shares of UnitedHealth Group from $675.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. Barclays lowered their target price on UnitedHealth Group from $604.00 to $603.00 and set an “overweight” rating for the company in a research note on Tuesday, October 22nd. Finally, Morgan Stanley decreased their price objective on UnitedHealth Group from $615.00 to $610.00 and set an “overweight” rating for the company in a report on Wednesday, October 16th. Three research analysts have rated the stock with a hold rating, eighteen have given a buy rating and two have issued a strong buy rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and a consensus price target of $615.53.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.